0 Valutazioni
ID

26720

Descrizione

Study ID: 100601 Clinical Study ID: LPL100601 Study Title: LPL100601, A Clinical Outcomes Study of Darapladib versus Placebo in Subjects with Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00799903 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: darapladib Study Indication: Atherosclerosis Study part: Pharmacogenetic research Withdrawal of consent

Keywords

versioni (4)
  1. 09/10/17 09/10/17 -
  2. 16/10/17 16/10/17 -
  3. 23/10/17 23/10/17 -
  4. 11/01/18 11/01/18 -
Titolare del copyright

GlaxoSmithKline

Caricato su

23 ottobre 2017

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY-NC 3.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

  • i più nuovi
  • i più vecchi
  • Popolare
  • i più nuovi
    • i più nuovi
    • i più vecchi
    • Popolare

    Non ci sono commenti

    Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

    Pharmacogenetic research Withdrawal of consent GSK study Chronic Coronary Heart Disease NCT00799903

    Inglese

    Pharmacogenetic research Withdrawal of consent Subject Identification GSK study Chronic Coronary Heart Disease NCT00799903

    1 moduli  
    Withdrawal of consent for PGx (DNA) / Blood sample destruction
    Descrizione

    Withdrawal of consent for PGx (DNA) / Blood sample destruction

    1. Has subject withdrawn consent for PGx research?
    Descrizione

    withdrawal consent for PGx research

    Tipo di dati

    boolean

    If subject has withdrawn consent for PGx research: date informed consent withdrawn
    Descrizione

    date informed consent withdrawn

    Tipo di dati

    date

    2. Has a request been made for blood sample destruction?
    Descrizione

    request for blood sample destruction

    Tipo di dati

    boolean

    If a request has been made for blood sample destruction, check reason
    Descrizione

    request for blood sample destruction reason

    Tipo di dati

    text

    If other reason applied, specify
    Descrizione

    request for blood sample destruction other reason

    Tipo di dati

    text

    Ritorna all'inizio della pagina

    Similar models

    Pharmacogenetic research Withdrawal of consent Subject Identification GSK study Chronic Coronary Heart Disease NCT00799903

    1 moduli
    Name
    genere
    Description | Question | Decode (Coded Value)
    Tipo di dati
    Alias
    Item Group
    Withdrawal of consent for PGx (DNA) / Blood sample destruction
    withdrawal consent for PGx research
    Item
    1. Has subject withdrawn consent for PGx research?
    boolean
    date informed consent withdrawn
    Item
    If subject has withdrawn consent for PGx research: date informed consent withdrawn
    date
    request for blood sample destruction
    Item
    2. Has a request been made for blood sample destruction?
    boolean
    Item
    If a request has been made for blood sample destruction, check reason
    text
    undefined item
    Code List
    If a request has been made for blood sample destruction, check reason
    CL Item
    Subject withdrew consent for PGx (3)
    CL Item
    Other (Z)
    request for blood sample destruction other reason
    Item
    If other reason applied, specify
    text
    Ritorna all'inizio della pagina 

    Aiuto

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial